Unknown PHASE2 INTERVENTIONAL 2-arm NCT01291654

Paracetamol and Patent Ductus Arteriosus (PDA)

Paracetamol in the Treatment of Patent Ductus Arteriosus in the Premature Neonate

Sponsor: Shaare Zedek Medical Center

Updated 5 times since 2017 Last updated: Dec 18, 2012 Started: Apr 30, 2012 Primary completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Patent Ductus Arteriosus, this trial is ongoing. The trial is conducted by Shaare Zedek Medical Center and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shaare Zedek Medical Center

Data source: Shaare Zedek Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel